| AP-1 | Activator protein-1 |
| AFB1 | Aflatoxin B1 |
| Akt | Protein kinase B (PKB) |
| αSMA | α-Smooth muscle actin |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| BAK-1 | BCL2 Antagonist/Killer 1 |
| Bax | BCL2-associated X |
| Bcl-2 | B cell lymphoma gene 2 |
| Cdk | Cyclin-dependent kinase |
| c-Fos | C-Jun, c-Myc, and c-Src; proto-oncogenes |
| EBV | Epstein-Barr virus |
| ECM | Extracellular matrix |
| Egr1 | Early growth response-1 |
| ERK1/2 | Extracellular signal-regulated kinases 1 and 2 |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| GGT | γ-Glutamyl transpeptidase |
| GPx | Glutathione peroxidase |
| GSH | Glutathione |
| GST | Glutathione-S-transferase |
| γ-GT | γ-Glutamyltranspeptidase |
| HO-1 | Haem oxygenase-1 |
| H2O2 | Hydrogen peroxide |
| IFN-γ | Interferon-γ |
| IL-1 | Interleukin 1 |
| IL-6 | Interleukin 6 |
| iNOS | Inducible nitric oxide synthase |
| JAK1 | Janus kinase-1 |
| JNK | C-Jun-NH2-kinase |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| MEK1/2 | Mitogen-activated protein kinase kinase 1 and 2 |
| MLK3 | Mixed lineage kinase-3 |
| MMP-2 | Matrix metalloproteinase-2 |
| MT1-MMP | Membrane type I matrix metalloproteinase |
| mTOR | Mechanistic target of rapamycin |
| NF-κB | Nuclear factor kappa B |
| NGF | Nerve growth factor |
| NO | Nitric oxide |
| p21 | Cyclin-dependent kinase inhibitor p21 |
| PKCδ | Protein kinase Cδ |
| PI3K | Phosphoinositide 3-kinase |
| Rb | Retinoblastoma |
| ROS | Reactive oxygen species |
| SHP-1 | c-Src homology 2 domain-containing phosphatase-1 |
| SMAD2 | Mothers against decapentaplegic homolog 2 also known as SMAD family member 2 |
| SMase | Sphingomyelinase |
| STAT3 | Signal-transducer-and-activator-of-transcription-3 |
| TGFβ1 | Transforming growth factor β1 |
| TIMP-1 | Tissue inhibitor of matrix metalloproteinase-1 |
| TNF-α | Tumour necrosis factor-α TPA, 12-O-Tetradecanoylphorbol-13-acetate |
| VEGF | Vascular endothelial growth factor |